MBX Biosciences, Inc. (MBX)
66.76
-1.86
(-2.71%)
USD |
NASDAQ |
Aug 26, 16:00
66.74
-0.02
(-0.02%)
After-Hours: 20:00
MBX Biosciences 1 Year Total Returns (Daily) : 334.4% for Aug. 26, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 26, 2026 | 334.4% |
| August 25, 2026 | 394.0% |
| August 24, 2026 | 363.3% |
| August 21, 2026 | 368.8% |
| August 20, 2026 | 386.8% |
| August 19, 2026 | 413.5% |
| August 18, 2026 | 356.6% |
| August 17, 2026 | 363.8% |
| August 14, 2026 | 419.1% |
| August 13, 2026 | 418.0% |
| August 12, 2026 | 434.5% |
| August 11, 2026 | 486.2% |
| August 10, 2026 | 444.0% |
| August 07, 2026 | 509.3% |
| August 06, 2026 | 475.1% |
| August 05, 2026 | 464.7% |
| August 04, 2026 | 463.8% |
| August 03, 2026 | 368.4% |
| July 31, 2026 | 397.6% |
| July 30, 2026 | 329.1% |
| July 29, 2026 | 327.5% |
| July 28, 2026 | 312.8% |
| July 27, 2026 | 320.7% |
| July 24, 2026 | 375.8% |
| July 23, 2026 | 364.7% |
| Date | Value |
|---|---|
| July 22, 2026 | 398.3% |
| July 21, 2026 | 394.5% |
| July 20, 2026 | 411.8% |
| July 17, 2026 | 415.9% |
| July 16, 2026 | 369.2% |
| July 15, 2026 | 352.8% |
| July 14, 2026 | 308.0% |
| July 13, 2026 | 360.4% |
| July 10, 2026 | 392.3% |
| July 09, 2026 | 394.8% |
| July 08, 2026 | 372.4% |
| July 07, 2026 | 381.4% |
| July 06, 2026 | 362.7% |
| July 02, 2026 | 368.8% |
| July 01, 2026 | 381.7% |
| June 30, 2026 | 383.8% |
| June 29, 2026 | 400.9% |
| June 26, 2026 | 363.3% |
| June 25, 2026 | 322.9% |
| June 24, 2026 | 338.0% |
| June 23, 2026 | 376.8% |
| June 22, 2026 | 350.8% |
| June 18, 2026 | 318.6% |
| June 17, 2026 | 311.8% |
| June 16, 2026 | 281.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Amylyx Pharmaceuticals, Inc. | 304.8% |
| ANI Pharmaceuticals, Inc. | -18.86% |
| Corcept Therapeutics, Inc. | 72.20% |
| Veru, Inc. | -19.31% |
| Johnson & Johnson | 56.42% |